img

Global Chronic Kidney Disease (CKD) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Chronic Kidney Disease (CKD) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function.
Chronic Kidney Disease (CKD) Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chronic Kidney Disease (CKD) Drugs market is projected to reach US$ 15730 million in 2029, increasing from US$ 13990 million in 2022, with the CAGR of 1.7% during the period of 2024 to 2029. Demand from Hospitals and Specialty Clinics are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The hospitals segment, which is the current market leader, is expected to continue its dominance in this market over the next few years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chronic Kidney Disease (CKD) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer, Inc.
Amgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical Co., Ltd.
Segment by Type
ACE Inhibitors
Angiotensin-II Receptor Blockers
Calcium Channel Blockers
Beta BlockersBREVIBLOC, Bystolic
Others

Segment by Application


Hospitals
Specialty Clinics

Segment by Region


North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chronic Kidney Disease (CKD) Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chronic Kidney Disease (CKD) Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chronic Kidney Disease (CKD) Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chronic Kidney Disease (CKD) Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chronic Kidney Disease (CKD) Drugs introduction, etc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Chronic Kidney Disease (CKD) Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Chronic Kidney Disease (CKD) Drugs Market Overview
1.1 Chronic Kidney Disease (CKD) Drugs Product Overview
1.2 Chronic Kidney Disease (CKD) Drugs Market Segment by Type
1.2.1 ACE Inhibitors
1.2.2 Angiotensin-II Receptor Blockers
1.2.3 Calcium Channel Blockers
1.2.4 Beta Blockers: BREVIBLOC, Bystolic
1.2.5 Others
1.3 Global Chronic Kidney Disease (CKD) Drugs Market Size by Type
1.3.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Chronic Kidney Disease (CKD) Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Chronic Kidney Disease (CKD) Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Type (2018-2024)
2 Global Chronic Kidney Disease (CKD) Drugs Market Competition by Company
2.1 Global Top Players by Chronic Kidney Disease (CKD) Drugs Sales (2018-2024)
2.2 Global Top Players by Chronic Kidney Disease (CKD) Drugs Revenue (2018-2024)
2.3 Global Top Players by Chronic Kidney Disease (CKD) Drugs Price (2018-2024)
2.4 Global Top Manufacturers Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chronic Kidney Disease (CKD) Drugs Market Competitive Situation and Trends
2.5.1 Chronic Kidney Disease (CKD) Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Chronic Kidney Disease (CKD) Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market
2.8 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chronic Kidney Disease (CKD) Drugs Status and Outlook by Region
3.1 Global Chronic Kidney Disease (CKD) Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Chronic Kidney Disease (CKD) Drugs Historic Market Size by Region
3.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Chronic Kidney Disease (CKD) Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Chronic Kidney Disease (CKD) Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Chronic Kidney Disease (CKD) Drugs Forecasted Market Size by Region
3.3.1 Global Chronic Kidney Disease (CKD) Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Chronic Kidney Disease (CKD) Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Chronic Kidney Disease (CKD) Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Chronic Kidney Disease (CKD) Drugs by Application
4.1 Chronic Kidney Disease (CKD) Drugs Market Segment by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.2 Global Chronic Kidney Disease (CKD) Drugs Market Size by Application
4.2.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Chronic Kidney Disease (CKD) Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Chronic Kidney Disease (CKD) Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Breakdown by Application (2018-2024)
5 North America Chronic Kidney Disease (CKD) Drugs by Country
5.1 North America Chronic Kidney Disease (CKD) Drugs Historic Market Size by Country
5.1.1 North America Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Chronic Kidney Disease (CKD) Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Chronic Kidney Disease (CKD) Drugs Sales in Value by Country (2018-2024)
5.2 North America Chronic Kidney Disease (CKD) Drugs Forecasted Market Size by Country
5.2.1 North America Chronic Kidney Disease (CKD) Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Chronic Kidney Disease (CKD) Drugs Sales in Value by Country (2024-2029)
6 Europe Chronic Kidney Disease (CKD) Drugs by Country
6.1 Europe Chronic Kidney Disease (CKD) Drugs Historic Market Size by Country
6.1.1 Europe Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Chronic Kidney Disease (CKD) Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Chronic Kidney Disease (CKD) Drugs Sales in Value by Country (2018-2024)
6.2 Europe Chronic Kidney Disease (CKD) Drugs Forecasted Market Size by Country
6.2.1 Europe Chronic Kidney Disease (CKD) Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Chronic Kidney Disease (CKD) Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Chronic Kidney Disease (CKD) Drugs by Region
7.1 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales in Value by Region (2024-2029)
8 Latin America Chronic Kidney Disease (CKD) Drugs by Country
8.1 Latin America Chronic Kidney Disease (CKD) Drugs Historic Market Size by Country
8.1.1 Latin America Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Chronic Kidney Disease (CKD) Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Chronic Kidney Disease (CKD) Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Chronic Kidney Disease (CKD) Drugs Forecasted Market Size by Country
8.2.1 Latin America Chronic Kidney Disease (CKD) Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Chronic Kidney Disease (CKD) Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Chronic Kidney Disease (CKD) Drugs by Country
9.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer, Inc.
10.1.1 Pfizer, Inc. Company Information
10.1.2 Pfizer, Inc. Introduction and Business Overview
10.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Products Offered
10.1.5 Pfizer, Inc. Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Amgen Chronic Kidney Disease (CKD) Drugs Products Offered
10.2.5 Amgen Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche Chronic Kidney Disease (CKD) Drugs Products Offered
10.3.5 Roche Recent Development
10.4 GlaxoSmithKline (GSK)
10.4.1 GlaxoSmithKline (GSK) Company Information
10.4.2 GlaxoSmithKline (GSK) Introduction and Business Overview
10.4.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Products Offered
10.4.5 GlaxoSmithKline (GSK) Recent Development
10.5 Allergan
10.5.1 Allergan Company Information
10.5.2 Allergan Introduction and Business Overview
10.5.3 Allergan Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Allergan Chronic Kidney Disease (CKD) Drugs Products Offered
10.5.5 Allergan Recent Development
10.6 AbbVie
10.6.1 AbbVie Company Information
10.6.2 AbbVie Introduction and Business Overview
10.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AbbVie Chronic Kidney Disease (CKD) Drugs Products Offered
10.6.5 AbbVie Recent Development
10.7 Kissei Pharmaceutical Co., Ltd.
10.7.1 Kissei Pharmaceutical Co., Ltd. Company Information
10.7.2 Kissei Pharmaceutical Co., Ltd. Introduction and Business Overview
10.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Products Offered
10.7.5 Kissei Pharmaceutical Co., Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chronic Kidney Disease (CKD) Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chronic Kidney Disease (CKD) Drugs Industrial Chain Analysis
11.4 Chronic Kidney Disease (CKD) Drugs Market Dynamics
11.4.1 Chronic Kidney Disease (CKD) Drugs Industry Trends
11.4.2 Chronic Kidney Disease (CKD) Drugs Market Drivers
11.4.3 Chronic Kidney Disease (CKD) Drugs Market Challenges
11.4.4 Chronic Kidney Disease (CKD) Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chronic Kidney Disease (CKD) Drugs Distributors
12.3 Chronic Kidney Disease (CKD) Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of ACE Inhibitors
Table 2. Major Company of Angiotensin-II Receptor Blockers
Table 3. Major Company of Calcium Channel Blockers
Table 4. Major Company of Beta Blockers: BREVIBLOC, Bystolic
Table 5. Major Company of Others
Table 6. Global Chronic Kidney Disease (CKD) Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2024) & (K Units)
Table 8. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2024) & (US& Million)
Table 10. Global Chronic Kidney Disease (CKD) Drugs Market Share in Value by Type (2018-2024)
Table 11. Global Chronic Kidney Disease (CKD) Drugs Price by Type (2018-2024) & (USD/Unit)
Table 12. Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2024-2029) & (K Units)
Table 13. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type (2024-2029)
Table 14. Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2024-2029) & (US$ Million)
Table 15. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Type (2024-2029)
Table 16. Global Chronic Kidney Disease (CKD) Drugs Price by Type (2024-2029) & (USD/Unit)
Table 17. North America Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2024) & (K Units)
Table 18. North America Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Chronic Kidney Disease (CKD) Drugs Sales (K Units) by Type (2018-2024)
Table 20. Europe Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Chronic Kidney Disease (CKD) Drugs Sales (K Units) by Type (2018-2024)
Table 24. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Chronic Kidney Disease (CKD) Drugs Sales by Company (2018-2024) & (K Units)
Table 28. Global Chronic Kidney Disease (CKD) Drugs Sales Share by Company (2018-2024)
Table 29. Global Chronic Kidney Disease (CKD) Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Company (2018-2024)
Table 31. Global Market Chronic Kidney Disease (CKD) Drugs Price by Company (2018-2024) & (USD/Unit)
Table 32. Global Chronic Kidney Disease (CKD) Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Chronic Kidney Disease (CKD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Drugs as of 2022)
Table 35. Date of Key Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market
Table 36. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Chronic Kidney Disease (CKD) Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global Chronic Kidney Disease (CKD) Drugs Sales by Region (2018-2024) & (K Units)
Table 40. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Chronic Kidney Disease (CKD) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Region (2018-2024)
Table 43. Global Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 44. Global Chronic Kidney Disease (CKD) Drugs Sales by Region (2024-2029) & (K Units)
Table 45. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Region (2024-2029)
Table 46. Global Chronic Kidney Disease (CKD) Drugs Sales by Region (2024-2029) & (US$ Million)
Table 47. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Region (2024-2029)
Table 48. Global Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 49. Global Chronic Kidney Disease (CKD) Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) & (K Units)
Table 51. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application (2018-2024)
Table 54. Global Chronic Kidney Disease (CKD) Drugs Price by Application (2018-2024) & (USD/Unit)
Table 55. Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2024-2029) & (K Units)
Table 56. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Application (2024-2029)
Table 57. Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2024-2029) & (US$ Million)
Table 58. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application (2024-2029)
Table 59. Global Chronic Kidney Disease (CKD) Drugs Price by Application (2024-2029) & (USD/Unit)
Table 60. North America Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) (K Units)
Table 61. North America Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) (K Units)
Table 63. Europe Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) (K Units)
Table 67. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Chronic Kidney Disease (CKD) Drugs Sales by Country (2018-2024) & (K Units)
Table 71. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Chronic Kidney Disease (CKD) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Country (2018-2024)
Table 74. North America Chronic Kidney Disease (CKD) Drugs Sales by Country (2024-2029) & (K Units)
Table 75. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Country (2024-2029)
Table 76. North America Chronic Kidney Disease (CKD) Drugs Sales by Country (2024-2029) & (US$ Million)
Table 77. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Country (2024-2029)
Table 78. Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2018-2024) & (K Units)
Table 79. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2024-2029) & (K Units)
Table 83. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe Chronic Kidney Disease (CKD) Drugs Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country (2024-2029) & (K Units)
Table 99. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America Chronic Kidney Disease (CKD) Drugs Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2024-2029) & (K Units)
Table 107. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Country (2024-2029)
Table 110. Pfizer, Inc. Company Information
Table 111. Pfizer, Inc. Introduction and Business Overview
Table 112. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Product
Table 114. Pfizer, Inc. Recent Development
Table 115. Amgen Company Information
Table 116. Amgen Introduction and Business Overview
Table 117. Amgen Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Amgen Chronic Kidney Disease (CKD) Drugs Product
Table 119. Amgen Recent Development
Table 120. Roche Company Information
Table 121. Roche Introduction and Business Overview
Table 122. Roche Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Roche Chronic Kidney Disease (CKD) Drugs Product
Table 124. Roche Recent Development
Table 125. GlaxoSmithKline (GSK) Company Information
Table 126. GlaxoSmithKline (GSK) Introduction and Business Overview
Table 127. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Product
Table 129. GlaxoSmithKline (GSK) Recent Development
Table 130. Allergan Company Information
Table 131. Allergan Introduction and Business Overview
Table 132. Allergan Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Allergan Chronic Kidney Disease (CKD) Drugs Product
Table 134. Allergan Recent Development
Table 135. AbbVie Company Information
Table 136. AbbVie Introduction and Business Overview
Table 137. AbbVie Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. AbbVie Chronic Kidney Disease (CKD) Drugs Product
Table 139. AbbVie Recent Development
Table 140. Kissei Pharmaceutical Co., Ltd. Company Information
Table 141. Kissei Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 142. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Product
Table 144. Kissei Pharmaceutical Co., Ltd. Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Chronic Kidney Disease (CKD) Drugs Market Trends
Table 148. Chronic Kidney Disease (CKD) Drugs Market Drivers
Table 149. Chronic Kidney Disease (CKD) Drugs Market Challenges
Table 150. Chronic Kidney Disease (CKD) Drugs Market Restraints
Table 151. Chronic Kidney Disease (CKD) Drugs Distributors List
Table 152. Chronic Kidney Disease (CKD) Drugs Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Kidney Disease (CKD) Drugs Product Picture
Figure 2. Global Chronic Kidney Disease (CKD) Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Chronic Kidney Disease (CKD) Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Chronic Kidney Disease (CKD) Drugs Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of ACE Inhibitors
Figure 6. Global ACE Inhibitors Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Angiotensin-II Receptor Blockers
Figure 8. Global Angiotensin-II Receptor Blockers Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Calcium Channel Blockers
Figure 10. Global Calcium Channel Blockers Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Beta Blockers: BREVIBLOC, Bystolic
Figure 12. Global Beta Blockers: BREVIBLOC, Bystolic Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Global Chronic Kidney Disease (CKD) Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Type in 2022 & 2029
Figure 17. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type in 2022
Figure 18. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Type in 2022
Figure 19. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Type in 2022
Figure 23. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Kidney Disease (CKD) Drugs Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Kidney Disease (CKD) Drugs Revenue in 2022
Figure 29. Chronic Kidney Disease (CKD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospitals
Figure 31. Global Hospitals Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Specialty Clinics
Figure 33. Global Specialty Clinics Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Chronic Kidney Disease (CKD) Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Application in 2022 & 2029
Figure 36. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Application in 2022
Figure 37. North America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application in 2022
Figure 38. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application in 2022
Figure 42. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Chronic Kidney Disease (CKD) Drugs Manufacturing Cost Structure
Figure 47. Chronic Kidney Disease (CKD) Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed